Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC offers a cost-effective and fast approach to adapting global health economic models to European settings

MTRC is the leading provider of market access services in Europe. Since 2017 we have accomplished 700+ projects in Europe. We provide regular consulting services to 56% of the top 30 med tech companies and multiple SMEs. 

The typical scope of model adaptation includes adjustment of epidemiological data, validation of comparator, adaptation of resource use and cost data, and search for local utility data.  

MTRC has a unique ability to work on model adaptations due to its unparalleled knowledge of payment systems in 34 European countries. We worked on model adaptations in Belgium, Denmark, Finland, France, Germany, Italy, Norway, the Netherlands, Poland, Russia, Spain, Sweden, and the UK. 

Health economic models can be adapted for different situations:

  • Adaptations of early models for marketing purposes
  • Adaptations of models with the publication of results
  • Adaptations of models to support local reimbursement/HTA submissions

In our team, we match a deep reimbursement and health economic expertise. Our Director is a member of the Editorial Board of one of the leading health economics journals, the Journal of Medical Economics. All reporting is done in accordance with the Consolidated Health Economic Evaluation Reporting Standards (CHEERS Statement). 

The timeline for the update of the models starts from 4 weeks. 

Finally, we acknowledge the budget limitations of the med tech industry. We offer a cost-effective approach with the provision of high-quality (we are ISO 9001:2015-certified, and our average NPS is 10/10) but affordable (36% of our business comes from SMEs) service to our clients.

Learn more and contact us to discuss your needs here.